High‐level expression of PRSS3 correlates with metastasis and poor prognosis in patients with gastric cancer
- 25 March 2019
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 119 (8) , 1108-1121
Abstract
Background and Objectives: Serine protease‐3 (PRSS3) is a known contributor to the genesis and development of malignant tumors, although its role in gastric cancer (GC) is still unclear.Methods: PRSS3 expression in GC tissue samples and its relationship with clinicopathological features were analyzed. Effects of GC cellular responses to the introduction of small interfering RNA (siRNA)‐mediated and short hairpin RNA (shRNA)‐mediated interference with tumor PRSS3 expression were also assessed.Results: PRSS3 was significantly upregulated in GC tissues, and PRSS3 protein levels were higher in tumors that developed metastases soon after the surgery compared with those that remained metastasis‐free. High expression of PRSS3 was associated with tumor N staging and independently predictive of postoperative prognosis in patients with GC. The V1 variant of PRSS3 was primarily detected in GC tissue and cell lines, the others (V2‐V4) being scarcely detectable. Methylation and demethylation drugs had no impact on expression levels of any PRSS3 transcriptional variant. The downregulated PRSS3 expression suppressed GC cell growth, migration, and invasion in vitro and in vivo.Conclusions: PRSS3 appears to act as an oncogene of GC. High PRSS3 expression portends postoperative metastasis, serving as an effective biomarker of poor therapeutic outcomes.Keywords
Funding Information
- National Natural Science Foundation of China (81672409, No. 81672409)
- China Postdoctoral Science Foundation (2017T100393, 2016M590489)
This publication has 30 references indexed in Scilit:
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Poor Prognosis of Advanced Gastric Cancer with Metastatic Suprapancreatic Lymph NodesAnnals of Surgical Oncology, 2013
- PRSS3 promotes tumour growth and metastasis of human pancreatic cancerGut, 2010
- Keratinocytes Synthesize Enteropeptidase and Multiple Forms of Trypsinogen during Terminal DifferentiationJournal of Investigative Dermatology, 2010
- Mesotrypsin promotes malignant growth of breast cancer cells through shedding of CD109Breast Cancer Research and Treatment, 2009
- Epigenetic gene silencing in cancer: the DNA hypermethylomeHuman Molecular Genetics, 2007
- Demethylation-Linked Activation of Urokinase Plasminogen Activator Is Involved in Progression of Prostate CancerCancer Research, 2007
- Epigenetic silencing of the PRSS3 putative tumor suppressor gene in non‐small cell lung cancerMolecular Carcinogenesis, 2005
- Discovery of Aberrant Expression of R-RAS by Cancer-Linked DNA Hypomethylation in Gastric Cancer Using MicroarraysCancer Research, 2005
- Transcriptional regulation of urokinase (uPA) gene expression in breast cancer cells: Role of DNA methylation.International Journal of Cancer, 1999